EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees†.

@article{Horwich2019EAUESMOCS,
  title={EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees†.},
  author={A. Horwich and M. Babjuk and J. Bellmunt and H. M. Bruins and T. M. D. Reijke and M. Santis and S. Gillessen and N. James and S. Maclennan and J. Palou and T. Powles and M. Ribal and S. Shariat and T. Kwast and E. Xylinas and N. Agarwal and T. Arends and A. Bamias and A. Birtle and P. Black and B. Bochner and M. Bolla and J. Boormans and A. Bossi and A. Briganti and I. Brummelhuis and M. Burger and D. Castellano and R. Cathomas and A. Chiti and A. Choudhury and E. Comp{\'e}rat and S. Crabb and S. Culine and B. Bari and W. D. Blok and P. D. De Visschere and K. Decaestecker and K. Dimitropoulos and J. Dominguez-escrig and S. Fanti and V. Fonteyne and M. Frydenberg and J. Futterer and G. Gakis and B. Geavlete and P. Gontero and B. Grubm{\"u}ller and S. Hafeez and D. Hansel and A. Hartmann and Dickon Hayne and A. Henry and V. Hern{\'a}ndez and H. Herr and K. Herrmann and P. Hoskin and J. Huguet and B. Jereczek-Fossa and R. Jones and A. Kamat and V. Khoo and A. Kiltie and S. Krege and S. Ladoire and P. Lara and A. Leliveld and E. Linares-Espin{\'o}s and V. L{\o}gager and A. Lorch and Y. Loriot and R. Meijer and M. Mir and M. Moschini and H. Mostafid and A. M{\"u}ller and C. R. M{\"u}ller and J. N'Dow and A. Necchi and Y. Neuzillet and J. Oddens and J. Oldenburg and S. Osanto and W. Oyen and L. Pacheco-Figueiredo and H. Pappot and M. Patel and B. Pieters and K. Plass and M. Remzi and M. Retz and J. Richenberg and M. Rink and F. Roghmann and J. Rosenberg and M. Roupr{\^e}t and O. Rouvi{\`e}re and C. Salembier and A. Salminen and P. Sargos and S. Sengupta and A. Sherif and R. Smeenk and A. Smits and A. Stenzl and G. Thalmann and B. Tombal and B. Turkbey and S. V. Lauridsen and R. Valdagni and A. G. van der Heijden and H. V. Van Poppel and M. Vartolomei and E. Veskim{\"a}e and A. Vilaseca and F. A. V. Rivera and T. Wiegel and P. Wiklund and A. Williams and R. Zigeuner and J. Witjes},
  journal={Annals of oncology : official journal of the European Society for Medical Oncology},
  year={2019}
}
  • A. Horwich, M. Babjuk, +118 authors J. Witjes
  • Published 2019
  • Medicine
  • Annals of oncology : official journal of the European Society for Medical Oncology
BACKGROUND Although guidelines exist for advanced and variant bladder cancer management, evidence is limited/conflicting in some areas and the optimal approach remains controversial. OBJECTIVE To bring together a large multidisciplinary group of experts to develop consensus statements on controversial topics in bladder cancer management. DESIGN A steering committee compiled proposed statements regarding advanced and variant bladder cancer management which were assessed by 113 experts in a… Expand
27 Citations

Tables from this paper

Paper Mentions

Interventional Clinical Trial
treatment of primary focal resection plus lymph node dissection combined with chemotherapy and anti-programmed cell death 1(PD-1) for Oligometastasis of urothelial carcinoma.  
ConditionsBladder Urothelial Carcinoma
InterventionDrug, Procedure
Present and future perspective in the field of bladder cancer
  • PDF
Emerging diagnostic and therapeutic strategies for urothelial carcinoma
...
1
2
3
...

References

SHOWING 1-10 OF 83 REFERENCES
The updated EAU guidelines on muscle-invasive and metastatic bladder cancer.
  • 408
  • PDF
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update.
  • 496
  • PDF
The Role of Surgery in Metastatic Bladder Cancer: A Systematic Review.
  • 64
SEOM clinical guideline for treatment of muscle-invasive and metastatic urothelial bladder cancer (2018)
  • 11
  • PDF
Bladder cancer: ESMO Practice Guidelines for diagnosis, treatment and follow-up.
  • 242
Contemporary bladder cancer: variant histology may be a significant driver of disease.
  • 60
...
1
2
3
4
5
...